Becton Dickinson ( (BDX) ) has provided an update.
BD announced on July 22, 2026, that Executive Vice President Mike Garrison plans to retire from his role as president of the Medical Essentials and BioPharma Systems segments after more than 20 years with the company, effective Oct. 2. He will remain in his position through the end of the fiscal year to support a smooth transition following a career that included leading BD’s Medical segment and key businesses such as Medication Management Solutions and Surgery.
The company has launched a comprehensive search for a new president of Medical Essentials, while the BioPharma Systems segment will begin reporting directly to Chairman, CEO and President Tom Polen. This shift is intended to streamline BD’s operating model and underscores the strategic importance of BioPharma Systems as a growth driver, signaling continued emphasis on leadership stability and segment-focused execution for stakeholders.
The most recent analyst rating on (BDX) stock is a Hold
with a $175.00 price target.
To see the full list of analyst forecasts on Becton Dickinson stock,
see the BDX Stock Forecast page.
Spark’s Take on BDX Stock
According to Spark, TipRanks’ AI Analyst, BDX is a Neutral.
The score is driven by solid financial quality—especially strong free cash flow and improving leverage—plus supportive earnings-call guidance with raised adjusted EPS. These positives are tempered by weak technicals (price below key moving averages with negative MACD) and a less helpful valuation signal due to a negative P/E, alongside near-term operational headwinds (tariffs, China, and a temporary FDA-related shipment hold).
To see Spark’s full report on BDX stock,
click here.
More about Becton Dickinson
BD (Becton, Dickinson and Company) is one of the world’s largest pure-play medical technology companies, focused on medical essentials, connected care, biopharma systems and interventional solutions. The company delivers billions of products annually to healthcare providers globally, aiming to optimize clinical operations, improve patient care, enhance safety and expand access to healthcare.
Average Trading Volume: 2,794,570
Technical Sentiment Signal: Buy
Current Market Cap: $42.57B
Learn more about BDX stock on TipRanks’ Stock Analysis page.
Trending Articles:
This story was written using TipRanks's AI tools and reviewed by a TipRanks editor.